Chapter 4: CKD treatment in cancer survivors, from Clinical Practice Guidelines for the Management of Kidney Injury During Anticancer Drug Therapy 2022
Kenji Ishikura(Kitasato University), Motoko Yanagita(Kyoto University), Takuro Mizukami(NTT Medical Center), Takeshi Matsubara(Shimane University), Sho Sasaki(Kyoto University Hospital), Yusuke Okuda(Kitasato University), Chihiro Kondoh(Toranomon Hospital), Satoko Ichioka(Shiga University of Medical Science), Yugo Shibagaki(FIND), Kenji Omae(Fukushima Medical University Hospital), Junichi Hoshino(Japanese Society for Dialysis Therapy), Sumío Hirata(Ashiya University), Kenichiro Koitabashi, Koichi Suyama(Toranomon Hospital)
Cited by 0
Related Papers
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality
|Renal Replacement Therapy|2020|170